Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 4/20 | 0.54 |
| ▸ | NOS1 | P29475 | 4/20 | 0.54 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.54 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.54 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.54 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.47 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.46 |
| ▸ | ACR | P10323 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | TNF | P01375 | 1/20 | 0.41 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.41 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | PLK1 | P53350 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.37 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4863419 | 0.86 | NOS1 (0.56) | NOS3NOS1SLC22A2SLC22A1SLC22A3 | |
| SCHEMBL4853071 | 0.82 | CYP2D6 (0.64) | NOS3NOS1SLC22A2SLC22A1SLC22A3 | |
| SCHEMBL4854767 | 0.81 | NOS1 (0.58) | NOS3NOS1SLC22A2SLC22A1SLC22A3 | |
| SCHEMBL4856119 | 0.81 | NOS3 (0.58) | NOS3NOS1SLC22A2SLC22A1SLC22A3 | |
| SCHEMBL4857038 | 0.81 | NOS1 (0.58) | NOS3NOS1SLC22A2SLC22A1SLC22A3 | |
| SCHEMBL4852965 | 0.81 | NOS1 (0.58) | NOS3NOS1SLC22A2SLC22A1SLC22A3 | |
| SCHEMBL4864124 | 0.81 | NOS3 (0.58) | NOS3NOS1SLC22A2SLC22A1SLC22A3 | |
| SCHEMBL4857014 | 0.80 | MEN1 (0.66) | NOS3NOS1SLC22A2SLC22A1SLC22A3 | |
| SCHEMBL4861886 | 0.78 | NOS3 (0.54) | NOS3NOS1PRSS1ACRCYP2D6 | |
| SCHEMBL4861629 | 0.78 | NOS3 (0.54) | NOS3NOS1PRSS1ACRCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7365069-B2 | Pyrimidone derivatives | BEXEL PHARMACEUTICALS INC. (US) | 2008-04-29 | — | — | US | disclosed |
| US-20040259891-A1 | Novel pyrimidon derivatives | ORCHID CHEMICAL & PHARMACEUTICALS LIMITED (IN) | 2004-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040259891-A1 | Novel pyrimidon derivatives | TYMS, TPMT, TYMP | NOS3 3830/4885NOS1 3074/4885SLC22A2 1157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.